169 related articles for article (PubMed ID: 17502116)
21. Is spending on proton beam therapy for cancer going too far, too fast?
Epstein K
BMJ; 2012 Apr; 344():e2488. PubMed ID: 22511301
[No Abstract] [Full Text] [Related]
22. Current status of radiotherapy with proton and light ion beams.
Greco C; Wolden S
Cancer; 2007 Apr; 109(7):1227-38. PubMed ID: 17326046
[TBL] [Abstract][Full Text] [Related]
23. [History and current status of charged particle therapy in Japan].
Tsujii H
Igaku Butsuri; 2012; 32(3):98-103. PubMed ID: 24592678
[No Abstract] [Full Text] [Related]
24. Proton beam radiation therapy.
MacDonald SM; DeLaney TF; Loeffler JS
Cancer Invest; 2006 Mar; 24(2):199-208. PubMed ID: 16537190
[No Abstract] [Full Text] [Related]
25. Comparison of carbon ions versus protons.
Weber U; Kraft G
Cancer J; 2009; 15(4):325-32. PubMed ID: 19672150
[TBL] [Abstract][Full Text] [Related]
26. More precisely defined dose distributions are unlikely to affect cancer mortality.
Schulz RJ; Kagan AR
Med Phys; 2003 Feb; 30(2):276. PubMed ID: 12607847
[No Abstract] [Full Text] [Related]
27. HCPBM [Heavy Charged Particles in Biology & Medicine] and ENLIGHT [European Network for Light Ions] meetings, Oropa (Italy), June 2005.
Jones B
Br J Radiol; 2006 Apr; 79(940):278-84. PubMed ID: 16585718
[No Abstract] [Full Text] [Related]
28. [Photons and protons in radiation therapy. The prospects for developing a proton therapy based on a new Russian accelerator].
Gogin EE; Benetskiĭ BA; Kravchuk LV; Tiflov VV
Ter Arkh; 1996; 68(10):31-6. PubMed ID: 9026939
[TBL] [Abstract][Full Text] [Related]
29. Clinical evidence that more precisely defined dose distributions will improve cancer survival and decrease morbidity.
Keall PJ; Williamson JF
Med Phys; 2003 Jun; 30(6):1281-2. PubMed ID: 12852554
[No Abstract] [Full Text] [Related]
30. Laser-driven proton oncology--a unique new cancer therapy?
Ledingham KW; Galster W; Sauerbrey R
Br J Radiol; 2007 Nov; 80(959):855-8. PubMed ID: 17768168
[TBL] [Abstract][Full Text] [Related]
31. Proton beam therapy is effective in highly selected clinical indications.
Crellin A
BMJ; 2012 May; 344():e3192. PubMed ID: 22570206
[No Abstract] [Full Text] [Related]
32. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
33. ENLIGHT: European network for Light ion hadron therapy.
Dosanjh M; Amaldi U; Mayer R; Poetter R;
Radiother Oncol; 2018 Jul; 128(1):76-82. PubMed ID: 29625810
[TBL] [Abstract][Full Text] [Related]
34. Proton and neutron radiation in cancer treatment: clinical and economic outcomes.
Fleurette F; Charvet-Protat S
Bull Cancer Radiother; 1996; 83 Suppl():223s-7s. PubMed ID: 8949785
[TBL] [Abstract][Full Text] [Related]
35. [Is proton beam therapy the future of radiotherapy? Part I: clinical aspects].
Bouyon-Monteau A; Habrand JL; Datchary J; Alapetite C; Bolle S; Dendale R; Feuvret L; Helfre S; Calugaru V; Cosset JM; Bey P
Cancer Radiother; 2010 Dec; 14(8):727-38. PubMed ID: 20427218
[TBL] [Abstract][Full Text] [Related]
36. Point/counterpoint. Proton therapy is too expensive for the minimal potential improvements in outcome claimed.
Schulz RJ; Smith AR; Orton CG
Med Phys; 2007 Apr; 34(4):1135-8. PubMed ID: 17500444
[No Abstract] [Full Text] [Related]
37. [Application Status and Development Trends of Medical Proton and Heavy Ion Accelerators].
Yang X; Chen H; Chen J; Qiao Y; Ma L
Zhongguo Yi Liao Qi Xie Za Zhi; 2019 Jan; 43(1):37-42. PubMed ID: 30770689
[TBL] [Abstract][Full Text] [Related]
38. [Hadron therapy in carcinoma].
Vobornik S; Dalagija F
Med Arh; 2002; 56(4):229-32. PubMed ID: 12518541
[TBL] [Abstract][Full Text] [Related]
39. A review of ion sources for medical accelerators (invited).
Muramatsu M; Kitagawa A
Rev Sci Instrum; 2012 Feb; 83(2):02B909. PubMed ID: 22380341
[TBL] [Abstract][Full Text] [Related]
40. [Clinical evaluation and perspective of charged particle therapy].
Tsujii H
Nihon Rinsho; 1997 Jun; 55(6):1588-95. PubMed ID: 9200952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
